DVB
Deep-Value Investor, Ex-Tech Executive, Agentic Equity Research Builder
Bloom Energy's demand may not become revenue when customers struggle to secure financing. Capital is difficult to raise in this climate; a reading of management's AI discussion also points to permitting, local opposition and customer credit as obstacles despite robust demand. Even after good earnings, the shares did not look very bullish. x.com x.com
Bloom Energy is priced on cyclical demand from today's power bottleneck, so it will be repriced once that bottleneck eases. Its unique product solves the bottleneck within 60-90 days of an order, but plenty of alternative power is coming, even if it takes years. The timing is unknowable, months or years, making it unsuitable as a long-term holding for preserving wealth over decades. x.com
Bloom Energy's revenue is growing faster than cash collection. Q3 sales reached $1.24bn and the 2026 guide rose to $4.4-4.6bn, yet operating cash flow was -$27m despite $309m from customer deposits and deferred revenue. Contract assets rose $430m in the quarter and from $241m to $859m year to date. Its largest customer fell to 43% of revenue, but the second, at 26%, is a related party. Management calls the cash gap billing timing; Q4 cash flow tests that explanation. x.com x.com x.com
Bad macro conditions mean even Bloom Energy's strong growth is not enough for the stock right now. Wall St Engine reports Q3 revenue rose 138.1% year over year. x.com
Bloom Energy appears less capital intensive than other AI companies even while expanding capacity. It appears to have begun the year with $2.5 billion in cash and still has $2.5 billion despite spending on expansion. x.com
Bloom Energy's strengths are largely priced in, leaving a less attractive risk-reward at current prices. Its positioning, backlog and bottleneck role in the AI buildout are compelling, and the stock can keep going higher. But paying too much can lead to underperformance even when the business thesis is right, and the higher expectations climb, the less room there is for anything to go wrong. x.com
Bloom Energy is a great business priced as if it can't miss, at roughly 22x sales, so it now has to grow into its multiple. Per @StockSavvyShay, product revenue more than tripled in a year as Bloom's fuel cells deploy onsite in months versus nearly five years for grid interconnection. But crushing earnings and growing into a multiple are two very different problems, and the stock had already nearly halved from its June high going into the report. x.com
Bloom Energy could look cheap if it hits its revenue targets amid exploding demand for on-site power. Revenue is projected at $4.5B in 2026 and $16B by 2029, implying 3.5x 2029 sales at a $56B market cap. It ranks alongside Forgent Power Solutions, perhaps better, as a buy at current levels. x.com x.com
Bloom Energy's valuation is now a problem because the market no longer tolerates crazy valuations in AI, so further buying will need a justifiable price. Hunterbrook's short report on Bloom adds to the scrutiny. x.com
Bloom Energy is a great company with a large addressable market early in the AI buildout, but the stock has already front-run much of the expected growth after rising about 35-fold in two years. It should offer no gains for the next 12–18 months while it consolidates and digests that move, before probably breaking to new highs in 2028 or later. A pullback to $80–118 would be a good area to buy again. x.com x.com x.com
Bloom Energy's third beat-and-raise this year makes its selloff look driven by market fear rather than deteriorating business results. A similar sentiment-driven decline after strong results in July marked a bottom before the stock doubled; the setup looks similar now. x.com
Bloom Energy is a structural winner from AI data-center power shortages, but at $201 it is not cheap despite falling 42% from its high. It trades near 98x 2026 and 45x 2027 expected earnings after a 17-fold rise in two years, so the drop looks like an AI power premium normalizing. Q1 revenue grew 130% as margins and cash flow improved, but scandium supply and backlog-quality questions from Hunterbrook's short report remain open. A guidance cut on July 28 could send it to $150-160. x.com x.com
